These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28816516)

  • 1. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection.
    Wang MY; Liu XF; Xia J; Li Y; Geng JL; Hu CJ
    Future Microbiol; 2017 Sep; 12():953-965. PubMed ID: 28816516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant leukocidin domain of VvhA exotoxin of Vibrio vulnificus as an effective toxoid in mouse model.
    Lohith GK; Kingston JJ; Singh AK; Murali HS; Batra HV
    Immunol Lett; 2015 Sep; 167(1):47-53. PubMed ID: 26141623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant metalloprotease antigen of Vibrio vulnificus elicits protective antibodies in a murine model.
    Chen YC; Chang CC; Chang SY; Su JH
    Lett Appl Microbiol; 2010 Feb; 50(2):168-72. PubMed ID: 20002577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th2-related immune responses by the Brucella abortus cellular antigens, malate dehydrogenase, elongation factor, and arginase.
    Im YB; Shim S; Park WB; Kim S; Yoo HS
    Microb Pathog; 2017 Sep; 110():7-13. PubMed ID: 28629726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-21 Enhances the Immune Protection Induced by the Vibrio vulnificus Hemolysin A Protein.
    Sun KN; Huang F; Wang MY; Wu J; Hu CJ; Liu XF
    Inflammation; 2022 Aug; 45(4):1496-1506. PubMed ID: 35129769
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lee A; Kim MS; Cho D; Jang KK; Choi SH; Kim TS
    Front Immunol; 2018; 9():2095. PubMed ID: 30283443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swarming differentiation of vibrio vulnificus downregulates the expression of the vvhBA hemolysin gene via the LuxS quorum-sensing system.
    Kim MY; Park RY; Choi MH; Sun HY; Kim CM; Kim SY; Rhee JH; Shin SH
    J Microbiol; 2006 Apr; 44(2):226-32. PubMed ID: 16728960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of Vibrio vulnificus flagellin protein FlaB in a wound infection model.
    Yamazaki K; Kashimoto T; Hashimoto Y; Kado T; Ueno S
    J Vet Med Sci; 2018 Jan; 80(1):55-58. PubMed ID: 29142160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and characterization of monoclonal antibody against Vibrio vulnificus].
    Fu KF; Ma C; Guo JW; Qiao YY; Hao XH; Wang DP
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):279-81. PubMed ID: 22394637
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Guo RH; Lim JY; Tra My DN; Jo SJ; Park JU; Rhee JH; Kim YR
    Front Cell Infect Microbiol; 2018; 8():70. PubMed ID: 29600196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vibrio vulnificus infection induces the maturation and activation of dendritic cells with inflammatory Th17-polarizing ability.
    Lee A; Lim HX; Kim MS; Cho D; Jang KK; Choi SH; Kim TS
    Int J Mol Med; 2018 Jan; 41(1):531-540. PubMed ID: 29115398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
    Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
    Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of EpsC, a component of the type II secretion system, in the pathogenicity of Vibrio vulnificus.
    Hwang W; Lee NY; Kim J; Lee MA; Kim KS; Lee KH; Park SJ
    Infect Immun; 2011 Oct; 79(10):4068-80. PubMed ID: 21788383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Vibrio vulnificus hemolysin in vivo and its pathogenic significance.
    Lee SE; Ryu PY; Kim SY; Kim YR; Koh JT; Kim OJ; Chung SS; Choy HE; Rhee JH
    Biochem Biophys Res Commun; 2004 Nov; 324(1):86-91. PubMed ID: 15464986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and vaccine efficacy of an attenuated Vibrio vulnificus strain with deletions in major cytotoxin genes.
    Kim YR; Lee SE; Kim JR; Rhee JH
    FEMS Microbiol Lett; 2015 Dec; 362(23):fnv169. PubMed ID: 26381905
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Yuan Y; Feng Z; Wang J
    Front Immunol; 2020; 11():599439. PubMed ID: 33193453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron differentially regulates gene expression and extracellular secretion of Vibrio vulnificus cytolysin-hemolysin.
    Kim CM; Chung YY; Shin SH
    J Infect Dis; 2009 Aug; 200(4):582-9. PubMed ID: 19586415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of haemolysin (VvhA) production by ferric uptake regulator (Fur) in Vibrio vulnificus: repression of vvhA transcription by Fur and proteolysis of VvhA by Fur-repressive exoproteases.
    Lee HJ; Kim JA; Lee MA; Park SJ; Lee KH
    Mol Microbiol; 2013 May; 88(4):813-26. PubMed ID: 23560801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.
    Lee TH; Cha SS; Lee CS; Rhee JH; Chung KM
    Infect Immun; 2014 Nov; 82(11):4813-23. PubMed ID: 25156730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression and inactivation of Vibrio vulnificus hemolysin in cirrhotic ascites, a human ex vivo experimental system.
    Choi MH; Park RY; Sun HY; Kim CM; Bai YH; Lee SE; Kim SY; Kim YR; Rhee JH; Shin SH
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):226-32. PubMed ID: 16831209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.